CAMBRIDGE, England, April 17, 2015 /PRNewswire/ --
Inivata, a Cambridge, England-based clinical cancer genomics company announced today that their presence at the 2015 American Association for Cancer Research (AACR) Annual Meeting 2015 will include a presentation by co-founder Nitzan Rosenfeld and a poster presentation. Michael Stocum, CEO Inivata, is also attending April 18th - 22nd.
The presentation, entitled Monitoring the cancer genome in plasma using ctDNA, forms part of a session on Recent Advances in Diagnostics and Therapeutics Research and will be in Room 113, Pennsylvania Convention Center, from 11:45am - 12:05pm on Tuesday 21st April. The poster will be in Section 21, poster number 15 from 1:00pm - 5:00pm on 20th April and is entitled Assessment of clinical applications of circulating tumor DNA using an enhanced TAm-Seq platform.
These will highlight the wide applicability of ctDNA technology and Inivata's enhanced TAm-Seq platform. Inivata has recently announced a partnership with molecular diagnostics company Biodesix (USA) to develop and commercialize Next Generation Sequencing (NGS)-blood based tests for clinical applications in lung cancer. For further information or to arrange a meeting please contact us on [email protected] or via Twitter @Inivata.
Inivata is a clinical cancer genomics company focused on harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. Inivata develops clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. Novel applications of ctDNA are enabled by Inivata's technology platform which includes its proprietary, enhanced TAm-Seq™ technology. For more information on Inivata, please visit http://www.inivata.com
American Association of Cancer Research is hosting their annual meeting in Philadelphia, Pennsylvania on April 18th - 22nd. The AACR Annual Meeting 2015 will highlight the latest, most exciting discoveries in every area of cancer research and will provide a unique opportunity for investigators from all over the world to meet, interact, and share their insights. This year's meeting theme - "Bringing Cancer Discoveries to Patients" - underscores the vital and inextricable link between discovery and treatment, and it reinforces the fact that research underpins all the progress we are making in the field toward cancer cures.